维普期刊资源整合服务平台（V6.5）

94篇 您的检索式：作者名="Hezode"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)显示文摘	Chevaliez S Hezode C Soulier A et d	2011	Gastroenterology2011，141，1：	1
2	Hepatitis C virus-induced hepatocellar steatosis显示文摘	Castera L Chouteau P Hezode C	2005	Am J Gastroenterology2005，100，3：	1
3	Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C:indirect evidence of a role of hepatitis C virus genotype 3 in steatosis 显示文摘	CASTERA L HEZODE C ROUDOT-THORAVAL F	2004	Gut2004，53，3：	1
4	Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C显示文摘	Hezode C Roudot-Thoraval F Nguyen S	2005	Hepatology2005，42，1：	1
5	Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily显示文摘	Hezode C Chevaliez S Bouvier-Alias M	2007	J Heoatol2007，46，5：	1
6	Telaprevirand peginterferon with or without ribavirin for chronic HCV infec-tion显示文摘	HEZODE C FORESTIER N DUSHEIKO G	2009	N Engl J Med2009，360，18：	1
7	1094 100% SVR IN IL28B CC PATIENTS TREATED WITH 12 WEEKS OF TELAPREVIR, PEGINTERFERON AND RIBAVIRIN IN THE PROVE2 TRIAL显示文摘	J.-P. Bronowicki C. Hezode L. Bengtsson S. Pol M. Bourliere L. Serfaty V. de Ledinghen A. Tran Y. Benhamou J.-D. Grange P. Mathurin P. Marcellin C. Trepo J.-P. Zarski S. Seepersaud K. Kelliher M. Botfield J.-M. Pawlotsky	2012	Journal of Hepatology2012，，：	1
8	1376 THE ASPIRE TRIAL: TMC435 IN TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE-1 HCV INFECTION WHO HAVE FAILED PREVIOUS PEGIFN/RBV TREATMENT显示文摘	S. Zeuzem G.R. Foster M.W. Fried C. Hezode G.M. Hirschfleld I. Nikitin F. Poordad O. Lenz M. Peeters V. Sekar G. De Smedt	2011	Journal of Hepatology2011，，：	1
9	Routine dectection and quantification of hepatitis B Virus DNA in clinical laboratories:performance of three commercial assays 显示文摘	P awlotsky J M Bastie A Hezode C	2000	J Virol Methods2000，85，：	1
10	Telaprevir andpeginterferon withoutribavirin for chronic HCV infection 显示文摘	Hezode C Forestier N Dusheiko G	2009	NEngl J Med2009，360，30：	1
11	Effect of noradrenal and albumin in patients with type hepatrorenal syndrome:a pilotstudy显示文摘	DUVNUX C ZANDITENAS D HEZODE C	2002	Hepatology2002，36，2：	1
12	Antiviral strategies in hepatitis C virus infection显示文摘	Sarrazin C Hezode C Zeuzem S	2012	J Hepatol2012，，：	1
13	Effect of noradrenal and albumin in patients with type Ⅰ hepatrorenal syndrome:a pilot study显示文摘	Duvoux C Zanditenas D Hezode C	2002	Hepatology2002，36，2：	1
14	Effects of nonadrenaline and albumin in patients with 1 hepatorenal syndrome:A pilot study 显示文摘	Duvoux C Zanditenas D Hezode C	2002	Hepatology2002，36，：	1
15	Effects of noradrenalin and albumin in patients with type 1 hepatorenal syndrome:A Pilot study显示文摘	Duvoux C Zanditenas D Hezode C	2002	Hepatology2002，36，：	1
16	Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study显示文摘	Duvoux C Zanditenas D Hezode C	2002	Hepatology2002，36，2：	1
17	Effects of noradrenalin and albumin in patients with type 1 hepatorenal syndrome:apilot stydy 显示文摘	Duvoux C Zanditenas D Hezode C	2002	Hepatology2002，36，：	1
18	Effect of noradrenal and albumin in patients with type hepatrorenal syndrome : a pilot study显示文摘	DUVOUX C ZANDITENAS D HEZODE C	2002	Hepatology2002，36，2：	1
19	Daily cannabis smok- ing as a risk factor for progression of fibrosis in ehonic hepatitis C显示文摘	Hezode C Roudot-Thoraval F Nguyen S	2005	Hepatology2005，42，1：	1
20	ABT -450/rombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis显示文摘	POORDAD F HEZODE C TRINH R	2014	N EnglJ Med2014，370，21：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示